Clinical Trial Update: A SAD Study of ZT002 Injection in Healthy Participants [Phase 1]

View source ↗

Summary

A Phase 1 single-ascending-dose study of ZT002 injection conducted in healthy participants to assess safety and pharmacokinetics. Type 2 Diabetes Mellitus is li…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• ZT002 Injection

Snippet

Sponsor: Beijing QL Biopharmaceutical Co.,Ltd | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED